The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Lambert John A since 2008.
The trader's CIK number is 1229443.
At the time of the last reporting, Lambert John A was the Director of Novavax Inc. (stock ticker symbol NVAX).
Also see all insider trading activities at Novavax Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2009 | NVAX | 0 | $0 | 34,746 | $97,844 | 0 | $0 |
| 2008 | NVAX | 14,746 | $0 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2009-07-02 | NVAX | Sale | 34,746 | 2.82 | 97,844 |
| 2008-07-31 | NVAX | Buy | 14,746 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lambert John A (Director of Novavax Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.